# The Impact of Opportunistic Infections on the Distribution of Microbiota and Biofilm Profiles in Lungs
Quaglee Dragontacos


## Abstract
One of the most important reasons for action is the development of anticancer resistanc. In this work, we report the impact of invasive aspergillosis (IA) on the microbiological profile of lung, spine, and nervous system of BALB/c mice. We used quantitative real-time polymerase chain reaction (qRT-PCR) analysis to find out the profile associated with aspergillosis and the roles played by fungal growth and other fungal factors during aspergillosis.

We detected four major phyla in Aspergillus. Among these phyla, Firmicutes, Proteobacteria, Actinobacteria, and Bacteroidetes, and three minor ones in other Microsporidia. We detected a minor fungal genera in our MIA group. The MIA group had a higher fungal burden, which may have been due to lower costs of production and exposure to antifungal agents. Our results suggest that the lung is an important site of aspergillosis and that the lung fungal burden in IA is lower than in the other two groups.

The MIA group also had a higher fungal burden, which may have been due to lower costs of production and exposure to antifungal agents. Our results suggest that the lung is an important site of aspergillosis and that the lung fungal burden in MIA is lower than in the other two groups.

Our findings provide a novel perspective that may help develop new therapeutic strategies to deal with the growing trend of nosocomial fungal infections in the lung.

The incidence of invasive fungal infections (IFIs) continues to rise, and they are most prevalent in immunocompromised patients. The lung is the most common site of Aspergillus infections, and aspergillosis is the third most common cause of lung cancer in this region. Culture-independent identification methods like DNA sequencing are becoming increasingly useful for identifying Aspergillus species. In this work, we developed a DNA-based assay for the rapid and rapid detection of Aspergillus species, and evaluated its performance was relevant and meaningful.

 444 serum samples from 4348 kidney donors were collected from 1997-2010 and tested using the MIA group and the FilmArray ME panel.


## Introduction

PLOS authors have the option to publish the peer review history of their article (what does this mean?. If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

12 Jan 2020

21 Jan 2020

Dear Dr. Ravindra,

We are pleased to inform you that your manuscript, "A potential new potential host infection of a bacterial pathogen" has been editorially accepted for publication in PLOS ONE, and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process.

To ensure an efficient production and billing process, please log into “Production Manager” at https://www.editorialmanager.com/pone/, click the "Update" link at the top of the page, and update your user information to ensure an efficient production and billing process. IMPORTANT NOTES:

* PLOS ONE requirements (via Backlog): If your manuscript is a qualifying clinical trial article, and you have indicated that this article or its components are not specified by the PLOS ONE Developer Guidelines, your manuscript will be considered Front-Behn.


## Methods
pombe were cultured on malt extract agar (MEA; Oxoid, UK) at 28°C for 48 h, and then transferred to MEA with the addition of 10% (v/v) glycero. Cultures were maintained at 28°C. Prior to infection, the cell concentration was determined by plating on solid medium and the number of viable CFU/ml.

Lungs were removed and weighed and homogenised in PBS (0.1 M, pH 7.2) for bacterial cultures. Five hundred µl of this suspension was spread on MEA to assess bacterial growth. The colonies on the plates were counted and the number of viable CFU/ml was calculated.

The number of live CFU was calculated by counting the number of bacterial colonies that appeared on the centre of the plate, as previously described (10). The number of live bacteria was calculated by counting the number of bacteria that appeared in the centre of the plate, as previously described (11).

Lungs were cut into small pieces and the trachea was placed in a sterile vial, and the wax was wrapped with a parafilm and placed in a sterile vial. A sample of wax was then taken from the vial and then a piece of glass wool was used to wipe the wax. The wax was then dried for 48 h at 40°C to give the desired concentration of wax. The wax was then used for the subsequent experiments. The wax concentrations were measured by the Luminex method (8).

To estimate the number of fungi, the number of CFU/ml, as previously described (9), was calculated by counting the number of live bacteria that appeared in the centre of the wax and the number of live bacteria that appeared in the centre of the wax, as previously described (10). The number of live bacteria was calculated by counting the number of bacteria that appeared in the centre of the wax and the number of live bacteria that appeared in the wax, as previously described (10). The wax concentrations were measured by the Luminex method (8).

Lungs were cut into small pieces and the trachea was placed in a vial, and the wax was then wrapped with a parafilm, and then the wax was then dried for 48 h at 40°C to give the desired concentration of wax. The wax was then used for the subsequent experiments.


## Results
For BALF, the average time to emergence was .48 h (interquartile range, 0.49-1.22) and 0.65 h (interquartile range, 0.59-0.83) in BALF and 0.72 h (interquartile range, 0.44-0.93) in CSF, respectively (Fig 3A). For CSF, the average time to emergence was 0.76 h (interquartile range, 0.52-0.85) and 0.77 h (interquartile range, 0.53-0.82) in BALF and 0.74 h (interquartile range, 0.59-0.81) in blood, respectively (Fig 3B). In blood, the average time to emergence was 0.73 h (interquartile range, 0.45-0.86) and 0.78 h (interquartile range, 0.57-0.82) in BALF and 0.74 h (interquartile range, 0.57-0.82) in blood, respectively (Fig 3C). For CSF, the average time to emergence was 0.63 h (interquartile range, 0.45-0.86) and 0.70 h (interquartile range, 0.51-0.86) in BALF and 0.76 h (interquartile range, 0.55-0.86) in blood, respectively (Fig 3D).

The analysis of the distribution of microbiota and biofilm profiles in CSF and blood revealed that for microbiota, the clinical presentation was largely absent for all three groups (Fig 4). For all three groups, the incidence of microorganisms was significantly higher in the group with high fungal burden at the baseline (Fig 4).

The distribution of microbiota and biofilm profiles in CSF and blood was similar to the situation in blood, in that the incidence of microorganisms was significantly higher in the group with high fungal burden at the baseline (Fig 4).


## Discussion
2012; Moll and Hofman 2013. Indeed, the abundance of the Bacillus genus is higher in the lung compared to the blood sample (Figure 2). It is likely that both microbial communities are exposed to the same stresses and conditions that humans have encountered (as well as other sources of human disease). Although this study had some limitations, the results demonstrate that exposure to environmental stresses can trigger the development of disease. For example, several bacterial species were found in the air samples of healthy individuals. However, the exposure to air conditioners can also induce the development of respiratory pathogens.

The present study also found that the bacterial community in the lung and blood samples of healthy individuals differed significantly from that of the other tissues. The differences were attributed to the extent of lung injury, inflammatory mediators, and chemokines. The lung injury caused by bacterial infection may not only be related to the lower lung cell count, but also to the expansion of bacterial population. In addition, the bacterial community in the lung and blood samples of healthy individuals differed significantly from the bacterial community in the lung and blood samples of healthy individuals. In addition, the infection of bronchiectasis patients could also be related to the development of bacterial infections. Moreover, the lung injury caused by bacterial infection could also be associated with the expansion of bacterial populations.

The findings that the bacterial communities in the lung and blood samples of healthy individuals were significantly different from that of the lung and blood samples of healthy individuals are in agreement with the results of other studies (Moll and Hofman 2013). For example, the bacterial community in the lung and blood samples of healthy individuals were significantly higher than that of the lung and blood samples of healthy individuals. Moreover, the bacterial community in the lung and blood samples of healthy individuals were significantly higher than that of the lung and blood samples of healthy individuals. These results are consistent with the results of several previous studies (Pereira et al. 2012; Lorenz et al. 2014; Lorenz et al. 2014; Lorenz and Lorenz 2017).

Biofilm formation can be triggered by various types of microbial factors (Bukowska et al. 2016).
